Home » Search
Search Results
4,603 results for 'mental health'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Can Lilly afford to maintain its dividend?
As shareholders gather April 19 for Eli Lilly and Co.’s annual meeting, more of them than ever will come with an unusual question:
Will Lilly be able to keep paying its dividend?Q&A: Jim Parker
Jim Parker was an executive at Anthem Blue Cross and Blue Shield and WellPoint for 14 years, including a year and a half as
chief of staff to CEO Angela Braly. He now is president of his own consulting firm, Meridian Strategic Advisors, in Indianapolis.
He spoke about the impact of the new health reform law on health insurers.Butler’s lofty goals may require jump to bigger conference
The idea of Butler University joining the Big Ten once seemed laughable. But so did coming within a basket of beating Duke
for the NCAA hoops title. Finances and desire for growth could force the Bulldogs to consider leaping from the Horizon League.HENDERSON: The real reasons not to merge utilities
Part of the overall utility problem is that lack of government oversight and public policy vision has made Indianapolis one
of the highest-polluting and just plain ugliest cities in the Midwest.Butler’s Bannister chose to chase an impossible dream
Butler's run to the Final Four has its roots in a decision two decades removed by a former school president and a group
of trusting trustees who dared to believe the impossible was possible for the Bulldogs.Spine center offering quick care for pain
An Indianapolis doctors' office has started an offshoot practice that specializes in quickly seeing patients with severe
back pain.EDITORIAL: Sports payoff is on the way through ‘legacy project’
Sports may be overemphasized in our society, but there’s no doubt they’ve been good to Indianapolis.
Docs fear reform will exacerbate ER overuse
One of the most agreed-upon reasons for health care reform was the expensive overuse of the emergency room by uninsured patients.
But two Hoosier ER docs—one conservative, one liberal—say the implementation of ObamaCare will leave that fundamental
problem unresolved.ITT ‘buying accreditation’ strategy makes critics uneasy
ITT Educational Services and other for-profit educators are buying not-for-profit colleges to gain access to their regional
accreditation. The tactic could fuel rapid growth but makes critics uncomfortable.PARENT: Take your brain out for a walk
Urban life has
serious costs; it actually impairs our ability to think.HICKS: Recession slows with costly job creation
While economists share broad agreement on a surprisingly large number of issues, the most visible discord lies in how two
groups view the causes of recession.Job searches dragging on a year later
Out of six professionals IBJ profiled a year ago, three have found jobs, although all have accepted lower pay than
they were getting before. One could not be reached, but she still lists herself as looking for work on LinkedIn.com. Two tried
to start their own businesses, with one giving up and one, Bruce Flanagan, still trying.Consumer group touts financial benefits of energy efficiency
Opponents of energy/climate change legislation—which has predominantly been in the form of so-called cap-and-trade
legislation—aren’t convinced.Dow AgroSciences considered expansion elsewhere
Agricultural biotech firm hired a site-selection consultant and considered other cities around the world for its $340 million
expansion.Local government reform still sputtering
The second legislative session since the Kernan-Shepard report on local government reform is about to end. Joe Kernan and
Randall Shepard can still say, “We’ve got to stop governing like this.”
Company news
Call it California screamin.’ Indianapolis-based WellPoint Inc. continues to get a steady flow of
bad news coming from the Golden State, which is feeding problems for the health insurer in Washington, D.C. WellPoint CEO
Angela Braly gave an unapologetic defense last week before a congressional committee about her company’s 25-percent
premium hike on individual customers in California. But the next day, California Attorney General Jerry Brown subpoaned documents
from WellPoint and its insurance peers in an investigation into whether their premium increases and claims denials were illegal.
According to Bloomberg News, the investigation was undertaken in response to reports that California insurance providers deny
almost 40 percent of claims. Then on Monday, a consumer watchdog group sued WellPoint for pushing consumers to take coverage
with fewer benefits and higher deductibles, which the lawsuit says violates California law, according to the Associated Press.
On Thursday, President Obama’s top health official, Kathleen Sebelius, wants to see WellPoint and its rivals in her
office to explain their premium hikes. Heavy media attention on premium hikes in states across the country has revived Obama’s
health reform efforts, which WellPoint has opposed since last fall. The only good news for WellPoint came on Wall Street,
where investors are pleased the company is raising its prices faster than medical costs are escalating. WellPoint’s
stock price surged 6 percent last week alone.The Indiana University Melvin and Bren Simon Cancer Center has named a replacement for former director Stephen
Williams, who died of cancer in February 2009. The center chose Dr. Patrick J. Loehrer Sr., who joined the IU faculty in 1990,
and also will serve as associate dean for cancer research and hold the title HH Gregg Professor of Oncology at the IU School
of Medicine. Loehrer is an internationally recognized researcher and specialist in testicular cancer, gastrointestinal cancer,
and thymoma. His appointment must be approved by university trustes.Indianapolis-based PDS Biotechnology Corp. won a $1.28 million grant from the National Cancer Institute
to help it complete preclinical testing of an experimental drug aimed at curing infections and cancers caused by human papillomavirus.
The most common cancers caused by the virus are cervical, anal and head and neck cancers. PDS said 400 million people have
the virus, and no existing vaccines offer a cure.The University of Notre Dame licensed technology developed by one of its professors to Pennsylvania-based
Molecular Targeting Technologies Inc. Financial terms of the deal were not disclosed. The technology, developed by chemistry
prof Bradley Smith, can target dead or dying cells in humans or in bacteria clusters. Such selective sensing could help researchers
see more clearly the effects of treatments on cancers or bacterial infections.To attack costs, Lilly accelerates R&D
With President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep
getting higher for Eli Lilly and Co.’s efforts to develop drugs faster and cheaper.Officials: Weak smoking ban hurts Indianapolis’ hospitality efforts
The ongoing smoking-ban debate is getting a new spark from convention leaders trying to light a fire under
lawmakers, who have been reluctant to approve the kind of comprehensive smoking ban that
health—and now tourism—officials say is needed here.